Search research articles
Contact Us
Filters
Showing results (271-280 of 313) with videos related to
Page
of 32
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 22, 2024
Publisher Correction: Ketamine reduces the neural distinction between self- and other-produced affective touch: a randomized double-blind placebo-controlled study
Reinoud Kaldewaij, Paula C Salamone, Adam Enmalm, et al.
Alcoholism, Clinical and Experimental Research
|
September 8, 2011
The biometric measurement of alcohol consumption
Lawrence D Snell, Vijay A Ramchandani, Laura Saba, et al.
Biological Psychiatry
|
May 18, 2019
Striatal Dopamine Release in Response to Morphine: A [<sup>11</sup>C]Raclopride Positron Emission Tomography Study in Healthy Men
Primavera A Spagnolo, Alane Kimes, Melanie L Schwandt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 25, 2024
Ketamine reduces the neural distinction between self- and other-produced affective touch: a randomized double-blind placebo-controlled study
Reinoud Kaldewaij, Paula C Salamone, Adam Enmalm, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2009
Functional CRH variation increases stress-induced alcohol consumption in primates
Christina S Barr, Rachel L Dvoskin, Manisha Gupte, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 9, 2007
3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism
Donald R Gehlert, Andrea Cippitelli, Annika Thorsell, et al.
Molecular Psychiatry
|
September 20, 2022
An epigenetic mechanism for over-consolidation of fear memories
Riccardo Barchiesi, Kanat Chanthongdee, Michele Petrella, et al.
Molecular Psychiatry
|
May 6, 2018
The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study
Mary R Lee, Jenica D Tapocik, Mwlod Ghareeb, et al.
Translational Psychiatry
|
February 6, 2026
Functional neuroimaging of fatty acid amide hydrolase inhibition in posttraumatic stress disorder: a randomized clinical trial
Ryann Tansey, Irene Perini, Gavin N Petrie, et al.
Archives of General Psychiatry
|
October 6, 2010
Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study
John C Umhau, Reza Momenan, Melanie L Schwandt, et al.
Page
of 32
Search research articles
Search
Showing results (271-280 of 313) with videos related to
Sort By:
Page
of 32
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
July 22, 2024
Publisher Correction: Ketamine reduces the neural distinction between self- and other-produced affective touch: a randomized double-blind placebo-controlled study
Reinoud Kaldewaij, Paula C Salamone, Adam Enmalm, et al.
Alcoholism, Clinical and Experimental Research
|
September 8, 2011
The biometric measurement of alcohol consumption
Lawrence D Snell, Vijay A Ramchandani, Laura Saba, et al.
Biological Psychiatry
|
May 18, 2019
Striatal Dopamine Release in Response to Morphine: A [<sup>11</sup>C]Raclopride Positron Emission Tomography Study in Healthy Men
Primavera A Spagnolo, Alane Kimes, Melanie L Schwandt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 25, 2024
Ketamine reduces the neural distinction between self- and other-produced affective touch: a randomized double-blind placebo-controlled study
Reinoud Kaldewaij, Paula C Salamone, Adam Enmalm, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2009
Functional CRH variation increases stress-induced alcohol consumption in primates
Christina S Barr, Rachel L Dvoskin, Manisha Gupte, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
March 9, 2007
3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism
Donald R Gehlert, Andrea Cippitelli, Annika Thorsell, et al.
Molecular Psychiatry
|
September 20, 2022
An epigenetic mechanism for over-consolidation of fear memories
Riccardo Barchiesi, Kanat Chanthongdee, Michele Petrella, et al.
Molecular Psychiatry
|
May 6, 2018
The novel ghrelin receptor inverse agonist PF-5190457 administered with alcohol: preclinical safety experiments and a phase 1b human laboratory study
Mary R Lee, Jenica D Tapocik, Mwlod Ghareeb, et al.
Translational Psychiatry
|
February 6, 2026
Functional neuroimaging of fatty acid amide hydrolase inhibition in posttraumatic stress disorder: a randomized clinical trial
Ryann Tansey, Irene Perini, Gavin N Petrie, et al.
Archives of General Psychiatry
|
October 6, 2010
Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study
John C Umhau, Reza Momenan, Melanie L Schwandt, et al.
Page
of 32